Loading clinical trials...
Loading clinical trials...
High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell (PBSC) Rescue for Neuroblastoma: Standard of Care Considerations
Conditions
Interventions
Carboplatin
Autologous stem cell infusion
+5 more
Locations
1
United States
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
Start Date
March 28, 2012
Primary Completion Date
May 30, 2023
Completion Date
May 30, 2023
Last Updated
February 26, 2024
NCT03050268
NCT06721689
NCT04308330
NCT06395103
NCT06541262
NCT06057948
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions